VANCOUVER, British Columbia, April 5, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Citigroup (NYSE:C), Microsoft (NASDAQ:MSFT), Abbott (NYSE:ABT), Texas Instruments (NASDAQ:TXN), Atmel (NASDAQ:ATML), and Monsanto (NYSE:MON).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Citigroup Inc. (NYSE:C): Citigroup Inc. (NYSE:C) announced on Tuesday that Michael Helfer will be promoted as company Vice Chairman. In addition, Rohan Weerasinghe will be appointed as company General Counsel and Corporate Secretary. Both appointments will be effective on June 1, 2012. In the last trading session, Citigroup Inc. shares ended lower by 3.66% to US$35.04 on over 45.67 million shares, above its 30-day average volume of 43.77 million shares. The company has a market capitalization of 102.69 billion. Investors may want to find out how company insiders like Executive Officers and Directors are thinking about the future business prospects of the company. Check this insider trade report for C here.
Read Full Report: http://www.insiderslab.com/PR3/040512A/C/Citigroup.pdf
Microsoft Corporation (NASDAQ:MSFT): Microsoft Corporation (NASDAQ:MSFT) will issue its financial results for third quarter fiscal year 2012 on April 19. The company has a market capitalization of 261.88 billion. Microsoft tumbled 2.29% on Wednesday to US$31.21. The stock was traded above average volume with 49.43 million shares traded, 6.7 million shares more than its daily average. In the past 52 weeks, Microsoft share prices have been bracketed by a low of US$23.65 and a high of US$32.95, and are now at US$31.21, 32% above that low price. Are insiders starting to take huge profits by selling shares or exercising stock options? Add MSFT into your watch list for insider trade now.
Read Full Report: http://www.insiderslab.com/PR3/040512A/MSFT/Microsoft.pdf
Abbott Laboratories (NYSE:ABT): Insiderslab.com found a substantial Market Option Sale made by company Senior Vice President, Established Products, Pharmaceutical Products Group -- Michael J. Warmuth on March 30, at stock price US$61.16. Disclose date: April 3. Insiderslab.com also found company Vice President, Controller, Greg W. Linder, sold 29,331 shares at stock price US$61.35 on March 27. Abbott Laboratories (NYSE:ABT) is scheduled to release its financial results for first quarter 2012 on April 18. The stock began the trading session with a price of US$61.12 and throughout the session climbed at a high of US$62.57 but when day-trade ended the stock finally advanced +0.52% to US$61.46. Abbott traded 14.20 million shares in the last trading session, well above its daily average of 7.27 million shares. Do you want to know when company insiders will buy their shares? Want to add and monitor this company on an on-going basis? It can be done for free by registering below.
Read Full Report: http://www.insiderslab.com/PR3/040512A/ABT/Abbott.pdf
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
Texas Instruments Incorporated (NASDAQ:TXN):
Read Full Report: http://www.insiderslab.com/PR3/040512A/TXN/TexasInstruments.pdf
Atmel Corporation (NASDAQ:ATML):
Read Full Report: http://www.insiderslab.com/PR3/040512A/ATML/Atmel.pdf
Monsanto Company (NYSE:MON):
Read Full Report: http://www.insiderslab.com/PR3/040512A/MON/Monsanto.pdf
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore. Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
SOURCE Insiderslab.com; Insiders.hk